Ketamine is classified as a club drug, a label it earned through its widespread use at raves and dance parties starting in the 1990s. But that label only tells part of the story. Ketamine is also a legitimate medical anesthetic, a pain management tool, and more recently, a breakthrough treatment for severe depression. Its dual identity as both a party drug and a therapeutic medication makes it one of the more unusual substances in modern pharmacology.
How Ketamine Became a Club Drug
Ketamine was first synthesized in the 1960s as a surgical anesthetic. Recreational use was first recorded around the same period but stayed relatively rare for decades. That changed in the 1990s, when large-scale techno parties and raves spread from the United States to the United Kingdom and across Europe. Ketamine became a staple alongside MDMA and other substances at these events, earning its reputation as a “club drug” that persists today.
On the street, ketamine goes by names like Special K, K, Kit Kat, and Vitamin K. It typically appears as a white powder (diverted from liquid medical vials and dried) or as a clear liquid. People snort it, swallow it, or occasionally inject it. The appeal in party settings comes from its ability to produce feelings of detachment, altered perception, and a floaty, dreamlike state at lower doses.
What Ketamine Does to the Brain
Ketamine is a dissociative drug, meaning it creates a sense of separation between your mind and your body. It works by blocking a specific type of receptor in the brain involved in learning, memory, and sensory processing. When ketamine enters an open receptor channel, it physically plugs it, stopping the normal flow of signals. This disruption is what produces the anesthetic, painkilling, and perception-altering effects.
At low doses, people feel relaxed, slightly numb, and mildly detached from their surroundings. At moderate doses, vision and hearing distort, movement becomes difficult, and time perception warps. At high doses, something very different happens.
The “K-Hole” Experience
A k-hole is what happens when someone takes enough ketamine to become profoundly disconnected from both their body and the world around them. It’s sometimes described as a state between intoxication and a coma. People in a k-hole typically cannot speak, move easily, or interact with others. Their awareness of the real environment fades while intense hallucinations, illusions, and feelings of floating or leaving the body take over. Some people describe it as a near-death or out-of-body experience.
This state is not the same as simply being “high.” It can be terrifying, disorienting, and physically dangerous, particularly in a crowded club or outdoor setting where a person who can’t move or communicate is extremely vulnerable. The dissociative threshold kicks in at roughly 1 to 1.5 mg/kg when the drug is injected intravenously, though the exact dose varies with how it’s taken and individual tolerance.
Medical Uses Beyond the Club Scene
Ketamine’s medical life is extensive and growing. In hospitals, it has been used as an anesthetic for decades, particularly in emergency and battlefield settings because it doesn’t suppress breathing the way most anesthetics do. It’s also used at lower doses for pain management.
The biggest shift in perception came in 2019, when the FDA approved esketamine, a nasal spray derived from one of ketamine’s molecular forms, for treatment-resistant depression. Clinical trials showed it could produce rapid antidepressant effects, sometimes within hours, in patients who hadn’t responded to standard medications. This was a major development for a condition that leaves millions of people cycling through ineffective treatments for years. The approval helped reframe ketamine from a “party drug” into a potential psychiatric tool, though the tension between those two identities remains.
The most common clinical trial applications for ketamine today are pain management (about 28% of trials) and anesthesia (about 22%), with depression research growing rapidly.
Legal Status
In the United States, ketamine is a Schedule III controlled substance under the DEA’s classification system. That means it has recognized medical uses but carries a moderate to low potential for physical and psychological dependence. It sits in the same category as testosterone and certain codeine products. Possessing ketamine without a prescription is illegal, and distributing it carries federal penalties.
This scheduling reflects ketamine’s split personality. It’s available by prescription and used in hospitals and clinics every day, yet purchasing it on the street for recreational use is a criminal offense.
Health Risks of Regular Use
Short-term risks include nausea, confusion, elevated blood pressure, and the vulnerability that comes with being unable to move or speak during a k-hole. But the most distinctive damage from ketamine shows up with chronic, heavy use, and it targets an organ most people wouldn’t expect: the bladder.
Ketamine-induced cystitis was first formally described in 2007 among daily users. The drug causes chronic inflammation of the bladder lining, and the symptoms are painful and disruptive: frequent urination, burning, blood in the urine, and intense pain above the pubic bone. One study found that among chronic ketamine users with severe urinary symptoms, nearly 89% had thickened bladder walls and 44% had swelling in the kidneys caused by backed-up urine. In biopsies, 75% of chronic users showed damage to the bladder’s protective inner lining along with signs of inflammatory response.
The damage can extend beyond the bladder. Prolonged use causes scarring of the bladder wall, reflux of urine back toward the kidneys, and in severe cases, chronic kidney failure. These aren’t rare complications in heavy users. They are a well-documented pattern that worsens the longer someone continues using.
There’s also a dependence risk. Research on large samples of recreational users has identified ketamine dependence as a real concern, and some researchers have raised questions about whether even therapeutic use of oral or nasal ketamine formulations could increase dependence risk over time, particularly in patients using it repeatedly for depression.
Risks in the Illicit Supply
Buying ketamine outside of medical channels carries an additional layer of danger that has nothing to do with ketamine itself. The illicit drug supply in the United States is increasingly contaminated with synthetic opioids like fentanyl, the veterinary sedative xylazine, potent novel opioids called nitazenes (some estimated to be ten times stronger than fentanyl), and variants of other sedatives. While these adulterants are most commonly associated with heroin and counterfeit pills, any powder purchased on the street can contain unexpected substances. A person who believes they’re snorting ketamine has no reliable way to verify what’s actually in it without using a drug checking service or fentanyl test strip.
Club Drug and Medicine at the Same Time
Ketamine occupies a genuinely unusual position. It is both a drug that people take at parties to feel detached from reality and a medication that doctors administer in operating rooms and psychiatric clinics. These aren’t two different substances or two different eras. They coexist right now. The same pharmacological properties that make ketamine useful for anesthesia and rapid-acting depression relief are what make it appealing recreationally: its ability to alter consciousness, dull pain, and create dissociation.
That overlap is why the “club drug” label, while accurate, is incomplete. Ketamine is a club drug in the same way that nitrous oxide is a dental tool or that amphetamines are ADHD medications. The context of use, the dose, and the supervision change everything about the risk profile, even though the molecule is the same.